Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib Trial of Encapsulated Rapamycin (eRapa) in Prostate Cancer Patients Under Active Surveillance

NCT03618355 is registered in ClinicalTrials.gov with Rapamycin Holdings, Inc. dba Emtora Biosciences as lead sponsor.

NCT NCT03618355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03618355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib Trial of Encapsulated Rapamycin (eRapa) in Prostate Cancer Patients Under Active Surveillance
Lead sponsor
Rapamycin Holdings, Inc. dba Emtora Biosciences
Phase
Phase 1
Overall status
Completed
Start date
August 28, 2018
Completion date
December 2, 2019
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer